Patient 1 and Patient 3 did not develop diabetes over the time of observation
GLP-1 effects, including the appetite suppression most people notice first, activate at moderate potency but become more pronounced as doses increase during titration
On the other side of the equation, 41 people would suffer from abdominal pain, 57 from hair loss, 8 from gallstones, 118 from constipation, 100 from diarrhea, 22 from dizziness, 84 from an upset stomach, 46 from excessive burping , 39 from fatigue, 51 from excessive farting , 13 from headaches, 17 from low blood sugars, 4 from reactions at the injection site, 221 from nausea, 4 from pancreatitis, 43 from upper abdominal pain, and 110 from vomiting
WHAT IS PEPTIDE THERAPY